Suppression of contact hypersensitivity to DNCB by previous intravenous injection of DNP-protein conjugate.
D000818:Animals; D000937:Antigen-Antibody Reactions; D001153:Arsphenamine / Q000494:pharmacology*; D003877:Dermatitis, Contact / Q000209:etiology*; D003888:Desensitization, Immunologic; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology*; D010853:Picryl Chloride / Q000494:pharmacology*; D011506:Proteins / Q000008:administration & dosage / Q000494:pharmacology; D012709:Serum Albumin / Q000008:administration & dosage / Q000494:pharmacology; D012882:Skin Tests
D009578:Nitrobenzenes; D011506:Proteins; D012709:Serum Albumin; D001153:Arsphenamine; D010853:Picryl Chloride